$ATRS Play The Breakout Above $3.96

NASDAQ:ATRS   Antares Pharma, Inc
It's been 2 years since $ATRS was last above $4 a share.

Might be some fireworks next week.

Antares Pharma , Inc. ( ATRS ) today announced that Robert F. Apple , President and Chief Executive Officer, will present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019 at 12:00 p.m. Eastern Time.

About Antares Pharma

Antares Pharma , Inc. is a combination drug device company focused primarily on the development and commercialization of self-administered parenteral pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. ( Teva ), AMAG Pharmaceuticals , Inc. and Pfizer Inc . ( Pfizer ). Antares Pharma’s proprietary products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva .

As always, trade with caution and use protective stops.

Good luck to all!
To receive our alerts via email and SMS, join Insider Financial for Free at

We are not financial advisors. Always conduct your own research and read our full disclaimer at


Great analysis.